Top
JAPANESE
Company Information
-
Flow cytometry using MAb 10E4, 3G10
HSase I (-)
10E4
3G10
HSase I (+
10E4
3G10
Cell line
KM 3
Common ALL
weakly+(10%)
Daudi
Burkitt lymphoma
EB 2
Burkitt lymphoma (ovary)
+(> 90%)
+(60%)
(50%)
(>90%)
CCRF-SB
ALL(B)
weakly+(50%)
(
)
(70%)
Molt 4
ALL(T)
HPBALL
ALL(T)
weakly+(20%)
(10%)
(90%)
K-562
erythroleukemia
+(80%)
(10%)
(90%)
PB (M)
normal human monocyte
PB (L)
normal human lymphocyte
PB (G)
normal human granulocyte
MKN 74
stomach cancer
+(100%)
(>90%)
(>90%)
COLO 201
colon cancer
+(80%)
(
)
(100%)
PLC/PRF/5
hepatoma
+(80%)
(
)
(50
60%)
Hep G2
hepatocellular carcinoma
+(100%)
(80%)
(100%)
G32TG
hepatocellular carcinoma
+(90%)
(
)
+:positive,
:negative,
:increase,
:decrease,
: no change, (%):positive rate
|
BACK
|
Monoclonals to Proteoglycans INDEX
|
NEXT
|